Question · asked by 1 review
Gabapentin vs placebo: Participant‐reported pain relief of 50% or greater
- Population
- people with diabetic peripheral neuropathy
- Intervention
- Gabapentin
- Comparison
- placebo
- Outcome
- Participant‐reported pain relief of 50% or greater
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Gabapentin vs placebo At least 50% pain intensity reduction · adults with peripheral diabetic neuropathy Gabapentin for chronic neuropathic pain in adults (2017) · Cochrane Headline outcomes only | no estimate extracted | 6 studies · 1331 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Gabapentin for chronic neuropathic pain in adults 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Gabapentin vs carbamazepine · intensive care unit in India · 1 review
- Gabapentin vs placebo · patients with pain in Guillain‐Barré syndrome · 1 review
- Gabapentin vs placebo · adults with postherpetic neuralgia · 1 review
- Gabapentin vs amitriptyline · children and adolescents with chronic non‐cancer pain · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.